CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Tonghua Golden-Horse Pharmcl Indu Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Tonghua Golden-Horse Pharmcl Indu Co Ltd
No. 999
Golden-horse Road, Erdaojiang District
Phone: +86 4353910232p:+86 4353910232 TONGHUA, JLN  134003  China Ticker: 000766000766
Business Summary
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd is a China-based company primarily engaged in the research, development, production, and sale of pharmaceutical products. The Company's products include traditional Chinese medicines, biochemicals, and active pharmaceutical ingredient (API)s, covering a wide range of areas, including anti-tumor, microbial, cardiovascular, heat-clearing and detoxification, digestive, musculoskeletal, gynecological, and nervous systems. The Company's products include Compound Lactobacillus Acidophilus Tablets, Rheumatism and Pain Relief Capsules, Liver-Clearing and Spleen-Strengthening Oral Liquid, and Qinshi Liyan Oral Liquid. The Company primarily operates in the domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202512/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager YufuZhang 60 8/20/2024 9/1/2019
Chief Financial Officer, Deputy General Manager, Director JunYu 52 7/12/2023 7/13/2006
Chief Marketing Officer, Deputy General Manager YuJing 43 4/1/2020 4/1/2020
10 additional Officers and Directors records available in full report.

General Information
Number of Employees: 1,532 (As of 12/31/2024)
Outstanding Shares: 966,494,707 (As of 6/30/2025)
Shareholders: 46,481
Stock Exchange: SHE
Fax Number: +86 4353910232


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, September 4, 2025
Register now for our FAST Rating webinar on September 10 at 2:00 PM ET!